(Q37512886)

20 August 2017

1 reference

title

Preeclampsia: the role of angiogenic factors in its pathogenesis (English)

1 reference

20 August 2017

0 references

0 references

0 references

3

S Ananth Karumanchi

1 reference

20 August 2017

Alice Wang

1

1 reference

20 August 2017

Sarosh Rana

series ordinal

2

1 reference

20 August 2017

publication date

1 June 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

24

1 reference

20 August 2017

page(s)

147-158

1 reference

Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Mild gestational hypertension remote from term: progression and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Vitamins C and E and the prevention of preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

World Health Organization systematic review of screening tests for preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

VEGF inhibition and renal thrombotic microangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Paternal and maternal components of the predisposition to preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Vascular endothelial growth factor induces endothelial fenestrations in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Decidual NK cells regulate key developmental processes at the human fetal-maternal interface.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

A reversible posterior leukoencephalopathy syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Hypoxia-reoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Changes in endothelial function precede the clinical disease in women in whom preeclampsia develops

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

An epidemiologic study of contraception and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Elevated serum soluble fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Nature of glomerular dysfunction in pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Circulating angiogenic factors and the risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Urinary Placental Growth Factor and Risk of Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Fetal and maternal contributions to risk of pre-eclampsia: population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Vascular endothelial growth factor localization in the adult.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Late postpartum eclampsia: report of two cases managed by uterine curettage and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Natural selection of FLT1 alleles and their association with malaria resistance in utero

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

VEGF(165) mediates glomerular endothelial repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Reversible posterior leukoencephalopathy syndrome and bevacizumab.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Altered blood pressure course during normal pregnancy and increased preeclampsia at high altitude (3100 meters) in Colorado

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Latest advances in understanding preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Preeclampsia: an endothelial cell disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Vitamins C and E and the risks of preeclampsia and perinatal complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Trophoblast deportation and the maternal inflammatory response in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

A novel human-specific soluble vascular endothelial growth factor receptor 1: cell-type-specific splicing and implications to vascular endothelial growth factor homeostasis and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Diagnosis, prevention, and management of eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Placental superoxide is increased in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

The Interval between Pregnancies and the Risk of Preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

A history of preeclampsia identifies women who have underlying cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Soluble endoglin contributes to the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Preeclampsia and the risk of end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Subclassification of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Maternal-placental interactions of oxidative stress and antioxidants in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Placental isoprostane is significantly increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Urine protein estimation in hypertensive pregnancy: which thresholds and laboratory assay best predict clinical outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Molecular epidemiology of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Blood pressure dynamics during pregnancy and spontaneous preterm birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

A sister's risk: Family history as a predictor of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSIOL.00043.2008

10.1152/PHYSIOL.00043.2008

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference